| Literature DB >> 19468330 |
Lars Carlsen1,2.
Abstract
The often observed scarcity of physical-chemical and well as toxicological data hampers the assessment of potentially hazardous chemicals released to the environment. In such cases Quantitative Structure-Activity Relationships/Quantitative Structure-Property Relationships (QSAR/QSPR) constitute an obvious alternative for rapidly, effectively and inexpensively generatng missing experimental values. However, typically further treatment of the data appears necessary, e.g., to elucidate the possible relations between the single compounds as well as implications and associations between the various parameters used for the combined characterization of the compounds under investigation. In the present paper the application of QSAR/QSPR in combination with Partial Order Ranking (POR) methodologies will be reviewed and new aspects using Formal Concept Analysis (FCA) will be introduced. Where POR constitutes an attractive method for, e.g., prioritizing a series of chemical substances based on a simultaneous inclusion of a range of parameters, FCA gives important information on the implications associations between the parameters. The combined approach thus constitutes an attractive method to a preliminary assessment of the impact on environmental and human health by primary pollutants or possibly by a primary pollutant well as a possible suite of transformation subsequent products that may be both persistent in and bioaccumulating and toxic. The present review focus on the environmental - and human health impact by residuals of the rocket fuel 1,1-dimethylhydrazine (heptyl) and its transformation products as an illustrative example.Entities:
Keywords: Environmental impacts; Human health impact; Partial Order Ranking, Hasse diagrams, Posets, Formal Concept Analysis; QSAR; QSPR; Risk assessment; Rocket fuel
Mesh:
Substances:
Year: 2009 PMID: 19468330 PMCID: PMC2680638 DOI: 10.3390/ijms10041628
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1.Transformation of 1,1-dimethylhydrazine in soil and water [5,6].
Calculated and experimentally determined physico-chemical parameters for the investigated substancesa [5].
| No | Log S | Log | Log | Log | Log |
|---|---|---|---|---|---|
| 1 | 1×106 (1×106) | −1.19 | 1.29 | 6.95×10−8 | 1.68×102 (1.57×102) |
| 2 | 1×106 (8.9×105) | 0.04 (0.16) | 1.17 | 1.28×10−4 (1.04×10−4) | 1.69×103 (1.61×103) |
| 3 | 1×106 (1.7×106) | −0.17 (−0.38) | 1.12 | 1.81×10−5 (1.77×10−5) | 1.52×103 (1.47×103) |
| 4 | 1×106 | 0.69 | 1.03 | 1.96×108 | 21.3 |
| 5 | 9.6×105 (1×106) | −0.64 (−0.57) | 1.58 | 2.02×10−6 (1.82×10−6) | 4.3 (2.70) |
| 6 | 1×106 (1×106) | −0.93 (−1.01) | 0.38 | 7.38×10−8 (7.39×10−8) | 3.49 (3.87) |
| 7 | 1×106 | −0.52 | 1.53 | 7.39×10−7 | 1.31×102 |
| 8 | 4.5×105 | 0.40 | 1.85 | 5.91×10−5 | 80.3 |
| 9 | 7.78×105 | 0.68 | 1.58 | 4.45×10−5 | 3.30×102 |
| 10 | 1×106 | −0.73 | 1.45 | 1.53×10−7 | 1.45×102 |
| 11 | 4.77×105 (1×106) | −0.17 (−0.34) | 0.18 | 6.78×10−5 (6.67×10−5) | 9.10×102 (9.02×102) |
| 12 | 1×106 | −1.70 | 0.65 | 3.08×10−10 | 0.14 |
| 13 | 1×106 | −0.44 | 1.00 | 1.52×10−8 | 7.12 |
| 14 | 3.02×104 (4.8×105) | 0.23 (−1.38) | 1.16 | 3.45×10−6 | 35.2 (7.51×103) |
| 15 | 3.1×105 (1×106) | −0.69 (−0.25) | 0.43 | 2.42×10−2 (1.33×10−4) | 7.32×102 (7.42×102) |
| 16 | 2.0×105 | 0.33 | 2.37 | 3.60×10−5 | 3.78 |
| 17 | 5.7×105 | −0.21 | 2.16 | 3.26×10−5 | 10.5 |
| 18 | 7.3×104 | 0.61 (0.23) | 1.20 | 7.88×10−5 | 11.5 |
a Values given in parentheses are experimental values as provided by the database associated with the EPI Suite.
Calculated persistence of the investigated structures in the environment [5].
| No. | Ultimate biodegradation half life within | Fast Anaerobic biodegradation? | Residence half life in rivers | Residence half life in lakes | |
|---|---|---|---|---|---|
| 1 | 3.0664 | Weeks | Yes | 272 d | 8.1 y |
| 2 | 2.8137 | Weeks | No | 5.1 h | 5.0 d |
| 3 | 3.1240 | Weeks | Yes | 22.9 h | 12.8 d |
| 4 | 2.9425 | Weeks | Yes | 3.67 y | 40.1 y |
| 5 | 2.6503 | Weeks to Months | Yes | 11.6 d | 130 d |
| 6 | 2.9834 | Weeks | No | 282 d | 8.4 y |
| 7 | 3.0044 | Weeks | Yes | 31.0 d | 340 d |
| 8 | 3.0088 | Weeks | No | 10.1 h | 7.9 d |
| 9 | 3.0398 | Weeks | Yes | 12.0 h | 8.4 d |
| 10 | 3.0354 | Weeks | Yes | 137 d | 4.1 y |
| 11 | 3.1241 | Weeks | Yes | 6.5 h | 5.3 d |
| 12 | 3.0045 | Weeks | Yes | 204 y | 2220 y |
| 13 | 2.6761 | Weeks to Months | No | 4.0 y | 44.0 y |
| 14 | 3.1615 | Weeks | No | 6.7 d | 6.7 d |
| 15 | 3.1394 | Weeks | Yes | 2.8 h | 3.1 d |
| 16 | 2.9097 | Weeks | No | 17.0 h | 11.2 d |
| 17 | 3.0155 | Weeks | Yes | 17.3 h | 11.1 d |
| 18 | 3.0177 | Weeks | No | 7.7 h | 6.6 d |
BDP3:Biodegradation potential for ultimate biodegradation [34]
h: hours, d: days, y: years. Biodegradation not taken into account
ECOSAR derived baseline and acute toxicity of the investigated compounds (values above 100 are rounded) [5].
| No. | ||||
|---|---|---|---|---|
| Fish | Fish | Daphnids | Green algae | |
| 1 | 48500 | 5.9 | 6.2 | 0.53 |
| 2 | 4050 | 290 | 16.8 | 16.1 |
| 3 | 4700 | 300 | 17.0 | 15.1 |
| 4 | 2160 | 1470 | 1450 | 830 |
| 5 | 19800 | 1000 | 5200 | 39.8 |
| 6 | 35000 | 30800 | 27000 | 14200 |
| 7 | 18500 | 4.4 | 6.1 | 0.67 |
| 8 | 2850 | 1.7 | 3.5 | 0.53 |
| 9 | 1350 | 1.1 | 2.5 | 0.42 |
| 10 | 23800 | 4.6 | 5.8 | 0.59 |
| 11 | 4600 | 17.8 | 48.8 | 1820 |
| 12 | 200000 | 14.4 | 12.2 | 0.88 |
| 13 | 15100 | 850 | 45.5 | 37.0 |
| 14 | 800 | 580 | 550 | 310 |
| 15 | 8000 | 6775 | 6025 | 3225 |
| 16 | 3700 | 2675 | 2550 | 1450 |
| 17 | 9400 | 7350 | 6775 | 3725 |
| 18 | 1800 | 1225 | 1200 | 690 |
a Baseline (non polar) toxicity (14 day’s test);
b polar toxicity 96 hrs;
c polar toxicity 48 hrs;
d polar toxicity 144 hrs
Figure 2.Lattice line diagram for ecotoxicological effects by 1,1-dimethylhydrazine and its transformation products as derived by EcoSAR [46].
ADME results (n/a: calculations not available) [6].
| No | Passive absorption (Human intestinal) | Absorption rate constant (min−1) | Binding constant log | P-Glycoprotein inhibitor | P-Glycoprotein substrate | ||
|---|---|---|---|---|---|---|---|
| 1 | 94 (10/90) | 0.012 | 14.71 | 1.70 | 0.94 | 0.003 | 0.031 |
| 2 | 99 (53/47) | 0.019 | 13.96 | 1.80 | 2.00 | 0.002 | 0.002 |
| 3 | 99 (18/82) | 0.018 | 11.74 | 1.65 | 2.29 | 0.004 | 0.014 |
| 4 | 100 (98/2) | 0.044 | 17.27 | 2.38 | 1.13 | 0.003 | 0.008 |
| 5 | 100 (88/12) | 0.022 | 7.25 | 2.19 | 1.01 | 0.003 | 0.006 |
| 6 | 94 (76/24) | 0.012 | 3.84 | 2.00 | 0.96 | 0.004 | 0.007 |
| 7 | 100 (95/5) | 0.031 | 17.49 | 2.24 | 1.22 | 0.003 | 0.010 |
| 8 | 100 (98/2) | 0.050 | 26.73 | 2.41 | 1.24 | 0.009 | 0.006 |
| 9 | 100 (93/7) | 0.031 | 19.85 | 2.22 | 1.14 | 0.005 | 0.005 |
| 10 | 93 (34/66) | 0.011 | 20.17 | 1.81 | 1.22 | 0.004 | 0.039 |
| 11 | 100 (74/26) | 0.022 | 5.67 | 2.10 | 1.03 | 0.004 | 0.006 |
| 12 | 89 (76/24) | 0.009 | 7.33 | 2.05 | 0.94 | 0.004 | 0.011 |
| 13 | 99 (91/9) | 0.019 | 22.82 | 2.14 | 1.02 | 0.009 | 0.006 |
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 15 | 99 (50/50) | 0.021 | 3.87 | 2.02 | 0.99 | 0.005 | 0.005 |
| 16 | 100 (94/6) | 0.027 | 12.51 | 2.47 | 1.04 | 0.005 | 0.009 |
| 17 | 99 (85/15) | 0.017 | 8.90 | 2.33 | 1.01 | 0.003 | 0.008 |
| 18 | 100 (94/6) | 0.032 | 12.64 | 2.49 | 1.14 | 0.005 | 0.009 |
a Values correspond to maximum passive absorption. Values in parentheses denote the respective transcellular/paracellular contributions
b Plasma Protein Bound fraction
c Volume of distrution
Predicted probabilities for the compounds to exhibit adverse organ specific health effects (n/a denotes that calculated values are not available) [6].
| No | ||||||
|---|---|---|---|---|---|---|
| Blood | Cardiovascular | Gastrointestinal | Kidney | Liver | Lungs | |
| 1 | 0.57 | 0.40 | 0.65 T | 0.28 | 0.48 T | 0.34 T |
| 2 | 0.44 | 0.34 | 0.80 | 0.20 | 0.18 | 0.27 |
| 3 | 0.20 | 0.31 | 0.26 | 0.11 | 0.20 T | 0.20 T |
| 4 | 0.79 | 0.07 | 0.92 | 0.57 | 0.85 | 0.74 |
| 5 | 0.76 | 0.06 | 0.97 | 0.75 T | 0.93 T | 0.71 T |
| 6 | 0.27 | 0.12 | 0.65 | 0.14 | 0.05 | 0.40 |
| 7 | 0.52 | 0.33 | 0.83 | 0.19 | 0.10 | 0.17 T |
| 8 | 0.63 | 0.06 | 0.84 | 0.31 | 0.05 | 0.75 |
| 9 | 0.32 | 0.08 | 0.90 | 0.42 | 0.07 | 0.72 |
| 10 | 0.53 | 0.64 | 0.66 | 0.14 | 0.29 T | 0.29 T |
| 11 | 0.19 | 0.08 | 0.25 | 0.09 | 0.04 | 0.04 T |
| 12 | 0.48 | 0.14 | 0.71 | 0.15 | 0.28 | 0.42 |
| 13 | 0.47 | 0.21 | 0.89 | 0.18 | 0.12 | 0.47 |
| 14 | n/a | N/a | n/a | n/a | n/a | n/a |
| 15 | 0.10 | 0.08 | 0.81 | 0.09 | 0.05 | 0.27 |
| 16 | 0.14 | 0.02 | 0.46 | 0.03 | 0.06 | 0.04 |
| 17 | 0.12 | 0.02 | 0.46 | 0.07 | 0.02 | 0.05 |
| 18 | 0.08 | 0.02 | 0.36 | 0.04 | 0.02 | 0.05 |
a T denotes that tumors have been found in experimental studies
Figure 3.Hasse diagram constructed based on the parameters GAS, LIV and LUN [6].
PASS predictions of selected biological activitiesa [6].
| No | Carcinogenic | Mutagenic | Teratogenic | Embryotoxic |
|---|---|---|---|---|
| 1 | 0.955 (0.002) | 0.762 (0.006) | 0.689 (0.031) | 0.672 (0.016) |
| 2 | 0.619 (0.001) | NE | NE | 0.527 (0.043) |
| 3 | NE | NE | 0.563 (0.062) | NE |
| 4 | 0.894 (0.003) | 0.792 (0.005) | 0.946 (0.006) | 0.816(0.007) |
| 5 | 0.980 (0.001) | 0.969 (0.002) | 0.952 (0.005) | 0.866 (0.005) |
| 6 | 0.951 (0.002) | NE | 0.614 (0.048) | 0.795 (0.009) |
| 7 | 0.827 (0.006) | 0.539 (0.010) | 0.698 (0.030) | 0.604 (0.026) |
| 8 | 0.980 (0.002) | NE | NE | NE |
| 9 | 0.683 (0.012) | NE | NE | NE |
| 10 | 0.923 (0.006) | 0.619 (0.007) | 0.811 (0.012) | 0.681 (0.015) |
| 11 | 0.628 (0.011) | NE | NE | NE |
| 12 | 0.897 (0.003) | 0.524 (0.011) | 0.530 (0.072) | NE |
| 13 | NE | NE | NE | NE |
| 14 | n/a | n/a | n/a | n/a |
| 15 | NE | NE | NE | NE |
| 16 | NE | NE | NE | NE |
| 17 | NE | NE | NE | NE |
| 18 | NE | NE | NE | NE |
a Values given are the calculated probability for the compounds to exhibit the effect (only values above 0.5 is given). Values in parentheses are the calculated probabilities for the compounds for not exhibiting the effect. NE indicates that if the compound exhibit the effect the probability will be below 0.5.
b n/a: PASS results not available for this compound
Figure 4.Hasse diagram constructed based on the parameters CAR, MUT, TER and EMB [6]. For calculation purposes probabilities < 0.5 (denoted NE in Table 6) are for ranking purposes arbitrarily set to 0.25 [6].
Averaged rank calculated according to eqn. 4 (na: calculations not available) [6].
| No | ||
|---|---|---|
| 1 | 6.0 | 2.8 |
| 2 | 6.8 | 9.7 |
| 3 | 13.5 | 9.7 |
| 4 | 1.1 | 2.8 |
| 5 | 1.2 | 1.0 |
| 6 | 11.5 | 3.0 |
| 7 | 8.0 | 5.1 |
| 8 | 2.6 | 3.6 |
| 9 | 4.0 | 10.1 |
| 10 | 6.0 | 2.6 |
| 11 | 16.9 | 11.3 |
| 12 | 5.4 | 6.0 |
| 13 | 4.9 | 17.0 |
| 14 | na | na |
| 15 | 10.8 | 17.0 |
| 16 | 15.0 | 17.0 |
| 17 | 15.6 | 17.0 |
| 18 | 16.8 | 17.0 |
a Rkav based on GAS, LIV, LUN
b Rkav based on CAR, MUT, TER, EMB
Figure 5.Hasse diagram constructed based on the meta descriptors originating from the ToxBoxes and the PASS calculations, respectively, cf. Table 7 [6].
Averaged rank calculated according to eqn. 4 Based on Tux Boxes and PASSS (HPOR approach) (n/a: calculations not available) [6].
| No | |
|---|---|
| 1 | 5.1 |
| 2 | 9.0 |
| 3 | 12.0 |
| 4 | 1.1 |
| 5 | 1.1 |
| 6 | 8.2 |
| 7 | 8.3 |
| 8 | 3.6 |
| 9 | 6.5 |
| 10 | 2.8 |
| 11 | 16.6 |
| 12 | 6.0 |
| 13 | 9.0 |
| 14 | n/a |
| 15 | 13.2 |
| 16 | 14.8 |
| 17 | 15.9 |
| 18 | 16.9 |
Figure 6.Lattice line diagram for human health effects by 1,1-dimethyl hydrazine and its transformation products as derived by PASS [35].
Selected implication sets from the formal concept analysis of human health effects by 1,1-dimethyl hydrazine and its transformation products as derived by PASS [35].
| No of compounds | If | Then |
|---|---|---|
| 7 | M > 50 | C > 60T > 50 |
| 5 | M > 60 | C > 60T > 60E > 60 |
| 1 | M > 90 | C > 90T > 90E > 80 |
| 7 | T > 60 | C > 60E > 60 |
| 4 | T > 80 | C > 60M > 60E > 60 |
| 3 | T > 90 | C > 60E > 80 |
| 4 | E > 70 | C > 60T > 60 |
| 3 | E > 80 | C > 60M > 70T > 90 |
Selected association rules from the formal concept analysis of human health effects by 1,1-dimethyl hydrazine and its transformation products as derived by PASS [35].
| No of compounds | Pct | If | Then |
|---|---|---|---|
| 7 / 8 | 88 | C > 60T > 50 | T > 60E > 60 |
| 7 / 8 | 88 | C > 60T > 50 | M> 50 |
| 7 / 8 | 88 | C > 80 | T > 50 |
| 6 / 7 | 86 | C > 60T > 60E > 60 | M > 50 |
| 6 / 7 | 86 | C > 60T > 60E > 60 | C > 80 |
| 6 / 7 | 86 | C > 60 M > 50T > 50 | C > 80 |
| 5 / 6 | 83 | C > 60M > 50T > 60E > 60 | M > 60 |
| 5 / 6 | 83 | C > 60M > 50T > 60E > 60 | C > 80 |
| 4 / 5 | 80 | C > 60M > 60T > 60E > 60 | T > 80 |
| 4 / 5 | 80 | C > 60M > 50T > 60E > 60 | M > 70 |
| 4 / 5 | 80 | C > 60M > 50T > 60E > 60 | C > 80 |
| 4 / 5 | 80 | C > 90 | T > 60 E > 60 |
Figure 7.Graphical representation of the hierarchical partial order ranking [16].
| BDP3 | Predicted Half-Lives (days) |
|---|---|
| Hours | 0.17 |
| Hours to Days | 1.25 |
| Days | 2.33 |
| Days to Weeks | 8.67 |
| Weeks | 15 |
| Weeks to Months | 37.5 |
| Months | 60 |
| Recalcitrant | 180 |
Context table for ecotoxicological effects by 1,1-dimethyl hydrazine and its transformation products as derived by EcoSARa [46].
| No. | F1000 | F100 | F10 | F5 | F1 | D1000 | D100 | D10 | D5 | D1 | A1000 | A100 | A10 | A5 | A1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | |||||||||||||||
| 2 | |||||||||||||||
| 3 | |||||||||||||||
| 4 | |||||||||||||||
| 5 | |||||||||||||||
| 6 | |||||||||||||||
| 7 | |||||||||||||||
| 8 | |||||||||||||||
| 9 | |||||||||||||||
| 10 | |||||||||||||||
| 11 | |||||||||||||||
| 12 | |||||||||||||||
| 13 | |||||||||||||||
| 14 | |||||||||||||||
| 15 | |||||||||||||||
| 16 | |||||||||||||||
| 17 | |||||||||||||||
| 18 |
a F1000, F100, F10, F5 and F1 denote EcoSAR derived toxicities towards fish being higher than 1,000, 100, 10, 5 and 1 mg/L, respectively. Analogously for D (daphnids) and A (algae).
Context table for carcinogenic, mutagenic, teratogenic and embryotoxic action by 1,1-dimethylhydrazine and its transformation products as derived by PASSa [35].
| No. | C5 | C6 | C7 | C8 | C9 | M5 | M6 | M7 | M8 | M9 | T5 | T6 | T7 | T8 | T9 | E5 | E6 | E7 | E8 | E9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||||||||||||||
| 2 | ||||||||||||||||||||
| 3 | ||||||||||||||||||||
| 4 | ||||||||||||||||||||
| 5 | ||||||||||||||||||||
| 6 | ||||||||||||||||||||
| 7 | ||||||||||||||||||||
| 8 | ||||||||||||||||||||
| 9 | ||||||||||||||||||||
| 10 | ||||||||||||||||||||
| 11 | ||||||||||||||||||||
| 12 | ||||||||||||||||||||
| 13 | ||||||||||||||||||||
| 15 | ||||||||||||||||||||
| 16 | ||||||||||||||||||||
| 17 | ||||||||||||||||||||
| 18 |
a C5, C6, C7, C8 and C9 denote PASS predicted probabilities for the compound being carcinogenic higher than 50, 60, 70, 80 and 90%, respectively. Analoguously for M (mutagenic), T (teratogenic) and E (embryotoxic).